Stevens Capital Management LP Incyte Corp Transaction History

Stevens Capital Management LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$51.18 - $63.75 $317,264 - $395,186	-6,199 Reduced 48.52%	6,576 $399,000
Q1 2024 May 08, 2024	BUY	$56.55 - $66.59 $143,410 - $168,872	2,536 Added 24.77%	12,775 $728,000
Q4 2023 Feb 02, 2024	SELL	$52.16 - $64.19 $747,035 - $919,329	-14,322 Reduced 58.31%	10,239 $643,000
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $844,019 - $963,237	14,610 Added 146.82%	24,561 $1.42 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $41,385 - $51,271	679 Added 7.32%	9,951 $619,000
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $651,172 - $797,484	9,272 New	9,272 $670,000
Q1 2020 Apr 21, 2020	SELL	$63.18 - $85.97 $1.93 Million - $2.63 Million	-30,570 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$73.04 - $95.72 $914,168 - $1.2 Million	12,516 Added 69.33%	30,570 $2.67 Million
Q3 2019 Nov 08, 2019	SELL	$72.82 - $86.52 $166,029 - $197,265	-2,280 Reduced 11.21%	18,054 $1.34 Million
Q2 2019 Jul 31, 2019	BUY	$73.52 - $88.7 $1.49 Million - $1.8 Million	20,334 New	20,334 $1.73 Million
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $1.81 Million - $2.18 Million	-29,327 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$60.85 - $83.98 $1.78 Million - $2.46 Million	29,327 New	29,327 $1.97 Million
Q1 2018 May 08, 2018	SELL	$83.06 - $100.98 $7.67 Million - $9.33 Million	-92,384 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$93.56 - $116.6 $8.64 Million - $10.8 Million	92,384	92,384 $8.75 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.